Nasdaq:US$15.94 (-0.85) | HKEX:HK$24.95 (-1.45) | AIM:£2.40 (-0.1)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor